Juluca
Dolutegravir Maintains Virologic Suppression in Multiple Trials
Dolutegravir-based regimens provide long-term suppression in HIV patients, according to presentations at the 22nd ...
JULY 26, 2018
FDA Approves Juluca, First 2-Drug Regimen for HIV
Juluca is the first complete treatment regimen containing only two drugs for the maintenance treatment of HIV-1 ...
NOVEMBER 22, 2017
Load more